Xencor reported $-41900000 in Operating Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US $ 4306M 135M
Alexion Pharmaceuticals ALXN:US $ 636.2M 14.1M
Alnylam Pharmaceuticals ALNY:US $ -181.68M 35.52M
Amgen AMGN:US $ 2378M 1550M
Arrowhead Research ARWR:US $ -64883000 33.02M
AstraZeneca AZN:LN -1674000000 2.8B
Biogen BIIB:US $ 794M 308.3M
Bristol Myers Squibb BMY:US $ 1996M 281M
Cytokinetics CYTK:US $ -69.2M 14.4M
Epizyme EPZM:US $ -64140000 5.91M
GlaxoSmithKline GSK:LN 1.94B 263M
Johnson & Johnson JNJ:US $ 3849M 2813M
Karyopharm Therapeutics KPTI:US $ -43812000 5.24M
Macrogenics MGNX:US $ -52987000 12.71M
Merk MRK:US $ 4826M 3212M
Novartis NOVN:VX 3.23B 246M
Pfizer PFE:US $ 7647M 1733M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M
Seattle Genetics SGEN:US $ -297.96M 208.36M
Xencor XNCR:US $ -41.9M 50.99M